PDCD1 and arthritic joint disease: Furthermore, systemic symptoms and signs-particularly arthralgia, arthritis, dry eyes, or nephropathy that frequently accompany idiopathic SCLE-are generally absent in PD-1/PD-L1 inhibitor-induced cases (39).